Gualberto Ruaño

6.2k total citations · 2 hit papers
108 papers, 3.6k citations indexed

About

Gualberto Ruaño is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Gualberto Ruaño has authored 108 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmacology, 37 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Gualberto Ruaño's work include Pharmacogenetics and Drug Metabolism (40 papers), Molecular Biology Techniques and Applications (14 papers) and Lipoproteins and Cardiovascular Health (13 papers). Gualberto Ruaño is often cited by papers focused on Pharmacogenetics and Drug Metabolism (40 papers), Molecular Biology Techniques and Applications (14 papers) and Lipoproteins and Cardiovascular Health (13 papers). Gualberto Ruaño collaborates with scholars based in United States, Puerto Rico and United Kingdom. Gualberto Ruaño's co-authors include Kenneth K. Kídd, Andreas Windemuth, Richard Judson, Jonathan Stephens, Krishnan Nandabalan, Stephen B. Liggett, Catharine B. Stack, Kevin Arnold, Dennis W. McGraw and Mohan Kocherla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Gualberto Ruaño

106 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complex promoter and coding region β ₂ -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

2000 745 citations Richard Judson, Gualberto Ruaño et al. profile →
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

2023 181 citations Jeffrey R. Strawn, Gualberto Ruaño et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gualberto Ruaño United States	30	1.2k	826	748	501	354	108	3.6k
Vidar M. Steen Norway	39	1.3k 1.0×	710 0.9×	763 1.0×	628 1.3×	204 0.6×	101	4.1k
Motohiro Kato Japan	42	1.7k 1.4×	752 0.9×	446 0.6×	279 0.6×	786 2.2×	354	6.8k
D Müller Germany	32	1.1k 0.9×	524 0.6×	484 0.6×	377 0.8×	225 0.6×	86	3.5k
Frank Skorpen Norway	35	2.1k 1.7×	518 0.6×	561 0.8×	876 1.7×	261 0.7×	84	5.1k
Ralph McGinnis United Kingdom	14	1.1k 0.9×	980 1.2×	2.1k 2.8×	204 0.4×	223 0.6×	25	4.5k
Laura C. Lazzeroni United States	35	1.3k 1.1×	202 0.2×	725 1.0×	372 0.7×	461 1.3×	96	4.6k
Bryan Dechairo United States	23	629 0.5×	541 0.7×	629 0.8×	437 0.9×	182 0.5×	43	2.2k
Ron Nudel Denmark	16	2.7k 2.2×	549 0.7×	912 1.2×	276 0.6×	216 0.6×	37	5.1k
Dana C. Crawford United States	35	2.1k 1.7×	741 0.9×	2.9k 3.9×	246 0.5×	643 1.8×	151	5.9k
Marco Cosentino Italy	46	1.5k 1.2×	188 0.2×	246 0.3×	645 1.3×	214 0.6×	239	6.9k

Countries citing papers authored by Gualberto Ruaño

Since Specialization

Citations

This map shows the geographic impact of Gualberto Ruaño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gualberto Ruaño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gualberto Ruaño more than expected).

Fields of papers citing papers by Gualberto Ruaño

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gualberto Ruaño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gualberto Ruaño. The network helps show where Gualberto Ruaño may publish in the future.

Co-authorship network of co-authors of Gualberto Ruaño

This figure shows the co-authorship network connecting the top 25 collaborators of Gualberto Ruaño. A scholar is included among the top collaborators of Gualberto Ruaño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gualberto Ruaño. Gualberto Ruaño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vlaar, Cornelis P., Jean‐Christophe M. Monbaliu, Rodolfo J. Romañach, et al.. (2024). A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities. International Journal of Pharmaceutics. 670. 125070–125070. 1 indexed citations

Malik, Salma, et al.. (2024). Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications. Journal of Child and Adolescent Psychopharmacology. 34(1). 4–20. 2 indexed citations

Duconge, Jorgé, et al.. (2023). An Expiration Date for Pharmacogenetic Test Results and Prescribing Guidance?. The Journal of Applied Laboratory Medicine. 8(4). 826–830. 1 indexed citations

Ruaño, Gualberto, et al.. (2020). Subanalysis of the CYP-GUIDES Trial: CYP2D6 Functional Stratification and Operational Timeline Selection. Psychiatry Research. 297. 113571–113571. 5 indexed citations

Hernández-Suárez, Dagmar F., Sona Rivas‐Tumanyan, Hetanshi Naik, et al.. (2020). Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial. BMJ Open. 10(8). e038936–e038936. 11 indexed citations

Baker, Seth, et al.. (2019). Ethnogeographic Prevalence and Implications of the 677C>T and 1298A>C MTHFR Polymorphisms in Us Primary Care Populations. Biomarkers in Medicine. 13(8). 649–661. 22 indexed citations

Lizano, Paulo, Olivia Lutz, George M. Ling, et al.. (2018). VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Translational Psychiatry. 8(1). 215–215. 10 indexed citations

Duconge, Jorgé, et al.. (2014). Pharmacogenetics of drug-metabolizing enzymes in US Hispanics. Drug Metabolism and Personalized Therapy. 30(2). 87–105. 24 indexed citations

Ruaño, Gualberto, Bonnie L. Szarek, Mohan Kocherla, et al.. (2013). Length of Psychiatric Hospitalization is Correlated With CYP2D6 Functional Status in Inpatients with Major Depressive Disorder. Biomarkers in Medicine. 7(3). 429–439. 32 indexed citations

10.

Ruaño, Gualberto, Bonnie L. Szarek, Andreas Windemuth, et al.. (2011). Physiogenomic Analysis of CYP450 Drug Metabolism Correlates Dyslipidemia With Pharmacogenetic Functional Status in Psychiatric Patients. Biomarkers in Medicine. 5(4). 439–449. 16 indexed citations

11.

Jagannathan, Kanchana, Vince D. Calhoun, Joel Gelernter, et al.. (2010). Genetic Associations of Brain Structural Networks in Schizophrenia: A Preliminary Study. Biological Psychiatry. 68(7). 657–666. 44 indexed citations

12.

Duconge, Jorgé, Carmen L. Cadilla, Andreas Windemuth, et al.. (2009). Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.. PubMed. 19(4). 390–5. 16 indexed citations

13.

Díaz, Francisco J., et al.. (2009). Acetyl-coenzyme A carboxylase α gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels. Schizophrenia Research. 115(2-3). 136–140. 14 indexed citations

14.

Ruaño, Gualberto, Andreas Windemuth, Mohan Kocherla, et al.. (2008). Increased Carrier Prevalence Of Deficient Cyp2C9 , Cyp2C19 and Cyp2D6 Alleles in Depressed Patients Referred to a Tertiary Psychiatric Hospital. Personalized Medicine. 5(6). 579–587. 10 indexed citations

15.

Seip, Richard L., Jeff S. Volek, Andreas Windemuth, et al.. (2008). Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat. Nutrition & Metabolism. 5(1). 4–4. 14 indexed citations

16.

Wang, Shuu‐Jiun, et al.. (2006). Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary. The Pharmacogenomics Journal. 6(2). 82–88. 24 indexed citations

17.

Judson, Richard, et al.. (2004). New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis. 177(2). 345–351. 45 indexed citations

18.

Tishkoff, Sarah A., et al.. (1996). Distribution and frequency of a polymorphic Alu insertion at the plasminogen activator locus in humans. Human Genetics. 97(6). 759–764. 9 indexed citations

19.

Choi, Julie, et al.. (1996). Assignment of the Acute Phase Response Factor (APRF) Gene to 17q21 by Microdissection Clone Sequencing and Fluorescencein SituHybridization of a P1 Clone. Genomics. 37(2). 264–265. 10 indexed citations

20.

Lee, Hsin‐Chen, et al.. (1991). Genetic Markers in Human Bone: I. Deoxyribonucleic Acid (DNA) Analysis. Journal of Forensic Sciences. 36(2). 320–330. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact